Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,047 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular Atrophy.
Baranello G, Gorni K, Daigl M, Kotzeva A, Evans R, Hawkins N, Scott DA, Mahajan A, Muntoni F, Servais L. Baranello G, et al. Among authors: evans r. Clin Pharmacol Ther. 2021 Dec;110(6):1435-1454. doi: 10.1002/cpt.2247. Epub 2021 Jun 5. Clin Pharmacol Ther. 2021. PMID: 33792051 Free PMC article.
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Evans R, Hawkins N, Dequen-O'Byrne P, McCrea C, Muston D, Gresty C, Ghate SR, Fan L, Hettle R, Abrams KR, de Bono J, Hussain M, Agarwal N. Evans R, et al. Target Oncol. 2021 Sep;16(5):613-623. doi: 10.1007/s11523-021-00837-y. Epub 2021 Sep 3. Target Oncol. 2021. PMID: 34478046 Free PMC article.
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC).
Muszbek N, Evans R, Remak E, Brennan VK, Colaone F, Shergill S, Ross P, Mullan D. Muszbek N, et al. Among authors: evans r. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):147-154. doi: 10.1080/14737167.2021.1973892. Epub 2021 Sep 6. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34488517
7,047 results